The discovery of orally-active pseudopeptide antagonists of the atrial natriuretic peptide clearance receptor

Robert T. Jacobs, David Aharony, Vernon Alford, Russell A. Bialecki, Steven E. Cook, Cathy L. Dantzman, Timothy W. Davenport, Steven T. Dock, Philip D. Edwards, Greg A. Hostetler, Alan Kirschner, Russell C. Mauger, Megan Murphy, William E. Palmer, Kara K. Pine, William L. Rumsey, Gary B. Steelman, Jean M. Surian, Mark Sylvester, Edward P. Vacek, and Chris A. Veale AstraZeneca, a Business Unit of Zeneca Inc., Wilmington, DE 19897, U.S.A.